Spada Alfred P. 4
4 · Conatus Pharmaceuticals Inc. · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Spada Alfred P.
SVP, R&D and CSO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-02-27−12,121→ 0 totalExercise: $1.24From: 2008-03-03Exp: 2018-03-02→ Common Stock (12,121 underlying) - Exercise/Conversion
Common Stock
2018-02-27$1.24/sh+12,121$15,030→ 12,121 total
Holdings
- 247,142(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Held by a family trust of which Dr. Spada is a trustee.